Literature DB >> 6329261

Preliminary results of proton beam irradiation of macular and paramacular melanomas.

E S Gragoudas, M Goitein, J Seddon, L Verhey, J Munzenrider, M Urie, H D Suit, P Blitzer, K N Johnson, A Koehler.   

Abstract

Proton beam irradiation has been used for the treatment of 60 eyes with choroidal melanomas located 3 mm or less from the fovea. The average follow-up period was 18 months. 86% of the treated lesions showed regression at the time of this analysis, and the 14% that did not were followed up for less than a year. Visual acuity remained the same in 47% of the treated eyes, improved in 20%, and deteriorated in 33%. 58% of the treated eyes had visual acuity of 20/100 or better at the last follow-up examination. Radiation vasculopathy with macular oedema was the most common complication, and it was observed in 22% of the treated eyes. These preliminary observations suggest that proton beam irradiation may be a reasonable alternative to enucleation even for this group of choroidal melanomas, which is considered unfavourable in respect of the preservation of visual function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329261      PMCID: PMC1040386          DOI: 10.1136/bjo.68.7.479

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  Long-term observations of proton-irradiated monkey eyes.

Authors:  E S Gragoudas; N Z Zakov; D M Albert; I J Constable
Journal:  Arch Ophthalmol       Date:  1979-11

2.  A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. VI. X-ray irradiation, carotid artery occlusion, collagen vascular disease, and vitritis.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1968-11

3.  Proton beam irradiation. An alternative to enucleation for intraocular melanomas.

Authors:  E S Gragoudas; M Goitein; L Verhey; J Munzenreider; H D Suit; A Koehler
Journal:  Ophthalmology       Date:  1980-06       Impact factor: 12.079

4.  Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study.

Authors:  E S Gragoudas; M Goitein; L Verhey; J Munzenreider; M Urie; H Suit; A Koehler
Journal:  Arch Ophthalmol       Date:  1982-06

5.  Radiotherapy for malignant melanoma of the choroid.

Authors:  H B Stallard
Journal:  Br J Ophthalmol       Date:  1966-03       Impact factor: 4.638

6.  Radiation retinopathy.

Authors:  G C Brown; J A Shields; G Sanborn; J J Augsburger; P J Savino; N J Schatz
Journal:  Ophthalmology       Date:  1982-12       Impact factor: 12.079

7.  Helium ion therapy for choroidal melanoma.

Authors:  D H Char; J R Castro
Journal:  Arch Ophthalmol       Date:  1982-06

8.  Posterior ocular abnormalities after irradiation for retinoblastoma: a histopathological study.

Authors:  P R Egbert; L F Fajardo; S S Donaldson; K Moazed
Journal:  Br J Ophthalmol       Date:  1980-09       Impact factor: 4.638

  8 in total
  3 in total

1.  Concurrent versus sequential application of ferromagnetic hyperthermia and 125I brachytherapy of melanoma in an animal model.

Authors:  W F Mieler
Journal:  Trans Am Ophthalmol Soc       Date:  1997

2.  Internal resection of posterior uveal melanomas.

Authors:  P J Kertes; J C Johnson; G A Peyman
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

3.  Optical coherence tomography angiography-based analysis of intrinsic vasculature in juxtapapillary melanoma after ruthenium-106 plaque brachytherapy.

Authors:  P Mahesh Shanmugam; Vinaya Kumar Konana; Rajesh Ramanjulu; K C Divyansh Mishra; Pradeep Sagar; Dilip Kumar
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.